Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report

被引:4
|
作者
Liu, Jing-Hua [1 ,2 ]
Gao, Qian [1 ]
Ma, Wen-Yi [1 ]
Cheng, Zi-Lin [1 ]
Luo, Na-Na [1 ]
Hao, Ping-Sheng [1 ,3 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Dept Dermatol, Chengdu, Sichuan, Peoples R China
[2] Dalian Dermatosis Hosp, Dalian, Liaoning, Peoples R China
[3] Hosp Chengdu Univ Tradit Chinese Med, 39 Shi er qiao Rd, Chengdu, Sichuan Provinc, Peoples R China
来源
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2023年 / 16卷
关键词
autoimmune bullous diseases; dupilumab; biologics; comorbidity; Chinese herbal compounds; USTEKINUMAB; THERAPY; PATIENT;
D O I
10.2147/CCID.S415019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is an immune-mediated chronic inflammatory disease that can be combined with complications such as diabetes, cardiovascular disease, obesity, and kidney disease. The comorbidity of psoriasis with autoimmune bullous diseases (AIBD) has been reported previously in several cases, the most frequent of which is bullous pemphigoid (BP). The underlying mechanisms of psoriasis with BP are not clear and there are no uniform treatment criteria. Based on previous case reports, the coexistence of psoriasis and BP may be related to inflammatory activity, medications, phototherapy, and infection. We report a case of a psoriasis patient who developed BP after taking Chinese herbal compounds and was successfully treated with dupilumab, which is the first reported case of applying dupilumab to treat psoriasis with BP comorbidities.
引用
收藏
页码:1583 / 1587
页数:5
相关论文
共 50 条
  • [31] Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature
    Wang, Jianbo
    Yu, Ling
    Zhang, Shuai
    Wang, Chen
    Li, Zhenlu
    Li, Ming
    Zhang, Shoumin
    JOURNAL OF DERMATOLOGY, 2022, 49 (01) : 165 - 167
  • [32] Coexistence of Pemphigus Foliaceus and Bullous Pemphigoid: A Case Report
    Yuan, Jinxiang
    Yao, Xinyi
    Liu, Lvye
    Zhang, Junling
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 2725 - 2731
  • [33] Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines
    Takamura, Saori
    Teraki, Yuichi
    JOURNAL OF DERMATOLOGY, 2022, 49 (09) : 845 - 850
  • [34] PUVA Induced Bullous Pemphigoid in a Patient with Psoriasis
    Marek-Jozefowicz, Lulza
    Scibior, Kinga
    Czajkowski, Rafal
    ACTA DERMATOVENEROLOGICA CROATICA, 2014, 22 (04) : 301 - 304
  • [35] Pemphigoid nodularis - rare presentation of bullous pemphigoid: A case report and literature review
    Vornicescu, Corina
    Senila, Simona Corina
    Cosgarea, Rodica
    Candrea, Elisabeta
    Pop, Alexandra Dana
    Ungureanu, Loredana
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (02) : 1132 - 1138
  • [36] PUVA-induced Bullous Pemphigoid in Psoriasis
    Caca-Biljanovska, Nina
    Arsovska-Bezhoska, Irina
    V'lckova-Laskoska, Marija
    ACTA DERMATOVENEROLOGICA CROATICA, 2016, 24 (03) : 214 - 217
  • [37] Successful treatment of psoriasis with interrupted adalimumab use: A case report
    Sakamoto, Sachiko
    Kawada, Akira
    Oiso, Naoki
    JOURNAL OF DERMATOLOGY, 2013, 40 (06) : 477 - 478
  • [38] Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature
    Chen, Jiaoquan
    Li, Huaping
    Zhu, Huilan
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2021, 14 : 1913 - 1917
  • [39] Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types
    Yan, Tianmeng
    Xie, Yinghan
    Liu, Yuhua
    Shan, Ying
    Wu, Xiaoyan
    Wang, Jing
    Zuo, Ya-Gang
    Zhang, Zhenying
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
    Wang, Si-Hang
    Zuo, Ya-Gang
    FRONTIERS IN IMMUNOLOGY, 2021, 12